Mutations in the LRRK2 gene are the most common known cause of familial and sporadic Parkinson’s disease (PD). Few studies performed to date to assess frequency of these mutations are actually only representative of specific areas. Here we study the frequency and clinical phenotype of LRRK2 G2019S, I2020T and R1441C/G/H mutations in 356 Sardinian patients with idiopathic PD and 208 controls. Seventeen additional subjects, relatives of PD mutated probands, were enrolled. Eight patients were mutated in heterozygosis for LRRK2 gene (2.3%): six carried the G2019S (1.7%) and two the R1441C (0.6%) mutation. Three PD patients G2019S carriers (50%) were detected in two contiguous villages comprising 3921 inhabitants while the other three (50...
Mutations in the LRRK2 and GBA genes are increasingly recognized as frequent determinants of familia...
Autosomal dominant parkinsonism has been attributed to pathogenic amino acid substitutions in leucin...
We determined the prevalence of two common leucine-rich repeat kinase 2 (LRRK2) gene mutations in A...
Mutations in the LRRK2 gene are the most common known cause of familial and sporadic Parkinson’s di...
Background: PARK8 is the most common known mendelian form of Parkinson's Disease (PD). It is due to ...
Mutations in the gene Leucine-Rich Repeat Kinase 2 (LRRK2) have been identified in both dominant and...
To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parki...
Mutations in the gene Leucine-Rich Repeat Kinase 2 (LRRK2) have been identified in both dominant and...
To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parki...
The Leucine-Rich Repeat Kinase 2 (LRRK2) Gly2019Ser mutation is frequent among Parkinson's disease (...
Leuchine-rich repeat kinase 2 (LRRK2) gene mutations are a common cause of familial and sporadic Par...
Background Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a cause of Pa...
Mutations in the LRRK2 gene, predominantly G2019S, have been reported in individuals with autosomal ...
Background Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a cause of Pa...
Background. The LRRK2 G2019S mutation is the most common genetic determinant of Parkinson’s disease ...
Mutations in the LRRK2 and GBA genes are increasingly recognized as frequent determinants of familia...
Autosomal dominant parkinsonism has been attributed to pathogenic amino acid substitutions in leucin...
We determined the prevalence of two common leucine-rich repeat kinase 2 (LRRK2) gene mutations in A...
Mutations in the LRRK2 gene are the most common known cause of familial and sporadic Parkinson’s di...
Background: PARK8 is the most common known mendelian form of Parkinson's Disease (PD). It is due to ...
Mutations in the gene Leucine-Rich Repeat Kinase 2 (LRRK2) have been identified in both dominant and...
To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parki...
Mutations in the gene Leucine-Rich Repeat Kinase 2 (LRRK2) have been identified in both dominant and...
To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parki...
The Leucine-Rich Repeat Kinase 2 (LRRK2) Gly2019Ser mutation is frequent among Parkinson's disease (...
Leuchine-rich repeat kinase 2 (LRRK2) gene mutations are a common cause of familial and sporadic Par...
Background Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a cause of Pa...
Mutations in the LRRK2 gene, predominantly G2019S, have been reported in individuals with autosomal ...
Background Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a cause of Pa...
Background. The LRRK2 G2019S mutation is the most common genetic determinant of Parkinson’s disease ...
Mutations in the LRRK2 and GBA genes are increasingly recognized as frequent determinants of familia...
Autosomal dominant parkinsonism has been attributed to pathogenic amino acid substitutions in leucin...
We determined the prevalence of two common leucine-rich repeat kinase 2 (LRRK2) gene mutations in A...